A model-based meta-analysis of monoclonal antibody pharmacokinetics to guide optimal first-in-human study design
about
Mathematical modeling of receptor occupancy data: A valuable technology for biotherapeutic drug development.Population pharmacokinetic and pharmacodynamic analysis of BIIB023, an anti-TNF-like weak inducer of apoptosis (anti-TWEAK) monoclonal antibody.Population pharmacokinetics analysis of VRC01, an HIV-1 broadly neutralizing monoclonal antibody, in healthy adults.Utility of a Bayesian Mathematical Model to Predict the Impact of Immunogenicity on Pharmacokinetics of Therapeutic Proteins.Impact of Shed/Soluble targets on the PK/PD of approved therapeutic monoclonal antibodies.Pharmacokinetics of Monoclonal Antibodies.
P2860
A model-based meta-analysis of monoclonal antibody pharmacokinetics to guide optimal first-in-human study design
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A model-based meta-analysis of ...... al first-in-human study design
@ast
A model-based meta-analysis of ...... al first-in-human study design
@en
A model-based meta-analysis of ...... al first-in-human study design
@nl
type
label
A model-based meta-analysis of ...... al first-in-human study design
@ast
A model-based meta-analysis of ...... al first-in-human study design
@en
A model-based meta-analysis of ...... al first-in-human study design
@nl
prefLabel
A model-based meta-analysis of ...... al first-in-human study design
@ast
A model-based meta-analysis of ...... al first-in-human study design
@en
A model-based meta-analysis of ...... al first-in-human study design
@nl
P2093
P2860
P356
P1476
A model-based meta-analysis of ...... al first-in-human study design
@en
P2093
Jasmine P Davda
John Gibbs
Megan A Gibbs
Michael G Dodds
Wendy Wisdom
P2860
P304
P356
10.4161/MABS.29095
P577
2014-05-16T00:00:00Z